# Cardinal Health, Inc. (CAH) · Edgar & Edgarette company card

> Cardinal Health (CAH) grew revenue 14.2% in FY2026 to $254.2 billion, operating margin 1.0%, in line with the 1.4% median for drugs, proprietaries & druggists' sundries, equity -5.0% of assets, and dividend per share up 18 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 721371 · fiscal year ended 2026-06-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/CAH) · [JSON](https://www.pops4.com/boards/company/CAH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $254.2B |
| Revenue growth, 1 year | 14.2% |
| Revenue growth per year | 8.8% |
| Operating margin | 1.0% (prior year 1.0%) |
| Net margin | 0.7% |
| Operating cash flow | $5.2B |
| Capital spending | $649M |
| Free cash flow | $4.5B |
| Cash | $4.9B |
| Long-term debt | $8.9B |
| Total assets | $57.3B |
| Total equity | −$2.9B |
| Equity ÷ assets | -5.0% |
| Return on equity | — |
| Dividend per share | $2.04 |
| Dividend years rising | 18 |

## Readings, computed from those figures

- Altman Z: -0.22 (distress zone)
- Piotroski F: 8 of 9 (strong)
- Beneish M: -2.74 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · liabilities exceed assets (often from years of share buybacks, not always distress)
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $254.2B (FY2026), total debt $8.9B. Experience: revenue up 14.2% on the year, up 8.8% a year over 4 years; operating margin 1.0%, up from 1.0%. Soundness: equity -5.0% of assets (liabilities exceed assets), payout 28.6% of profit, dividend per share up 18 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $249.8B and $297.2B next year (method v4.1: its own 5-year record of growth weighed at 57% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $231.4B to $318.7B. A statistical range, not company guidance. Against peers (30 filers, $50M+ revenue, its industry group): operating margin 1.0% against a 1.4% median; growth 14.2% against 0.9%.

Range logged 2026-09-24, receipt 2514c330b9f72f27, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-08-05 ([filing](https://www.sec.gov/Archives/edgar/data/721371/000072137126000026/0000721371-26-000026-index.htm))

## Recent filings

- 10-Q · filed 2026-11-05 · [filing](https://www.sec.gov/Archives/edgar/data/721371/000072137126000043/0000721371-26-000043-index.htm)
- 8-K · filed 2026-11-05 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/721371/000072137126000042/0000721371-26-000042-index.htm)
- 8-K · filed 2026-10-01 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/721371/000072137126000041/0000721371-26-000041-index.htm)
- DEF 14A · filed 2026-09-21 · [filing](https://www.sec.gov/Archives/edgar/data/721371/000130817926000402/0001308179-26-000402-index.htm)
- 10-K · filed 2026-08-11 · [filing](https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/0000721371-26-000038-index.htm)
- 8-K · filed 2026-08-11 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/721371/000072137126000037/0000721371-26-000037-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000721371.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=721371

## Cite

POPS4, Edgar & Edgarette: Cardinal Health, Inc. (CAH) company card, from the company's own SEC filings, accessed 2026-11-06, https://www.pops4.com/boards/company/CAH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.